China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Evaluation of the Effect of "DIY Healthy Drinks" Education on Promoting Children's Oral... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Evaluation of the Effects of Implicit Emotion Regulation Programs on the Fear of Patien... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A real-world study on Senaparib for first-line maintenance treatment in patients with n... Read More
Tokyo, Aug. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062535) titled 'A study comparing bowel habits, blood pressure,and glucose changes after 5-... Read More
Tokyo, Aug. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062554) titled 'Effects of repeated-sprint cycling training with breath holding on aerobic ... Read More
Tokyo, Aug. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062553) titled 'The effects of lavender aromatherapy and music therapy on sleep quality and... Read More
Tokyo, Aug. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062552) titled 'CT-based blood flow and structural analysis to identify rupture-prone regio... Read More
Singapore, Aug. 10 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and... Read More
Singapore, Aug. 10 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending ... Read More
Singapore, Aug. 10 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combin... Read More